Copyright
©The Author(s) 2017.
World J Clin Oncol. Apr 10, 2017; 8(2): 106-119
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.106
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.106
Markers | Localization | Ref. | Markers | Localization | Ref. |
CD44 | Cell surface | Guo et al[60], 2011 | MET | Cell surface | Baccelli et al[100], 2013 |
CD24 | Cell surface | Kakarala et al[94], 2008 | CD133 | Cell surface | Tume et al[101], 2016 |
Epcam | Cell surface | Chiotaki et al[95], 2015 | CD338 | Cell surface | Leccia et al[102], 2014 |
CD49f | Cell surface | Chiotaki et al[95], 2015 | ALDH1 | Cytoplasm | Guo et al[60], 2011 |
MUC1 | Cell surface | Nigam[96], 2013 | Bmi I | Cytoplasm | Kim et al[103], 2015 |
CD29 | Cell surface | Yeo et al[97], 2016 | GLI I | Cytoplasm | Fernandez-Zapico[104], 2013 |
CD61 | Cell surface | Yeo et al[97], 2016 | Sox2 | Cytoplasm | Feldman et al[91], 2012 |
CD47 | Cell surface | Zhang et al[98], 2015 | 4-Oct | Cytoplasm | Feldman et al[91], 2012 |
HER2 | Cell surface | Korkaya et al[90], 2008 | NANOG | Cytoplasm | McClements et al[105], 2013 |
eHSP90 | Cell surface | Stivarou et al[99], 2016 |
- Citation: Candelaria PV, Rampoldi A, Harbuzariu A, Gonzalez-Perez RR. Leptin signaling and cancer chemoresistance: Perspectives. World J Clin Oncol 2017; 8(2): 106-119
- URL: https://www.wjgnet.com/2218-4333/full/v8/i2/106.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i2.106